Image Alt

Research group in Health Sciences and Health Services

The Research Group in Health Sciences and Health Services (GRCS from Catalan) is a multidisciplinary group of professionals from different disciplines and institutions linked to the University of Andorra. It was created in 2008, and integrates a group of medical doctors from different specialties, pharmacists, chemists, biologists and nurses with a solid background in research.

GRCS’s mission is to create and transfer scientifically valid and socially relevant knowledge in biomedical and health services issues.

The GRCS intended to be a research group link to the university, respected by the international scientific community and to contribute to decision making in the field of health services in Andorra.

The GRCS is a response to the need to provide and process good quality information that helps in strategic decisions in different areas of Health Sciences and Health Services in Andorra, especially in the scientific field taking into account professional, social and political issues.

Objectives

GRCS General objectives:

  • To create and transfer scientifically valid and socially relevant knowledge in biomedical and health services issues.
  • To develop research focused on patient outcomes in Andorra.
  • To provide research specific knowledge and methodologies and to increase community participation.
  • To become a source of information that helps strategic decisions making in different areas of Health Sciences and Health Services in Andorra, especially in the scientific field taking professional, social and political issues into consideration.
  • To collaborate with all organizations involved in Andorra and to promote a Collaborative Research Network in Andorra.
  • To produce reports based on the best information available and to develop proposals or recommendations in different topics involved in the decision-making process.

Coordinators:

Elvira Gea – egea@uda.ad

Pharmacy Doctor. Hospital Pharmacy and Primary Care Specialist . PhD. Diploma in Ophthalmic Optics and Acoustics Audiometric. CAP Sciences. Master in Pharmaceutical Oncology. Master in Pharmacy Services.

 

Mercé Avellanet Viladomat – mavellanet@uda.ad

European board-certified Physical Medicine and Rehabilitation physician. MD. PhD.  Corporal damage assessment and medical expertise.Master. Master in Bioethics. Member of the European Academy of Rehabiltation Medicine

 

Collaborators:

Anna Boada Pladellorens

European board-certified Physical Medicine and Rehabilitation physician. MD. Master in Orthotics and Prostetics.

 

Meritxell Ros Armengol

Speech Therapist. Specialised in Dysphagia.

 

 

Francesc Garcia Cuyas

MD, PhD. Deputy Director Administration. Hospital Sant Joan de Déu. Barcelona

 

Josep Romagosa Massana

MD. Diploma on Hospital Management, ESADE. Barcelona. Diploma on  Methodology of Evaluation and Improvement of Care Quality. Avedis Donabedian Foundation. Barcelona. World Health Organization  Coordinator for Andorra

 

PhD Student:

Carlota de Miguel

Diploma in Nursing. Master in Telemedicine.

Research interests:

  1. Patterns of drug use as a starting point to reach a rational utilization of drugs.
  2. Patient safety.
  3. Health technology assessment.

Apart from these particular research interests, we are commited to research dynamization in the Andorran area within issues related to GRCS.

Current projects 

Orphan drugs and rare diseases. Prevalence in Andorra.

Drug safety for specific population:

  • Off labels use in Andorra
  • Dysphagia

Normali values for knee isokinetic dynamometer in Andorran population. Evaluta

Postural garment evaluation

Digital Health and health care processes reengineering

2019:

2018:

2017:

  • De Miguel C, Avellanet M, Garcia F. Salut Digital i Reenginyeria de Processos Assistencials: d’on partim, on som i a on anem? Agora 2017;21:7072.
  • Perez A, Gea E, Gil E, Perez A, Roca A. Third-degree atrioventricular block associated with donepezil. Eur J Clin Pharmacy 2017;19(5).
  • Avellanet M, Gonzalez-Viejo MA. People with Spinal Cord Injury in Spain. Am J Phys Med Rehabil 2017 Feb; 96(2 Suppl 1):S112-S115.
  • Perrot JC, Avellanet M, Lopez I, Ros M. Impacte de la disfagia a l’HNSM. Sessió de la Societat Catalana de Rehabilitació i medicina física. Acadèmia de Ciències Mèdiques de Catalunya i Balears. Barcelona, 30/05/2017. Sessió clínica.

2016:

  • Avellanet M, Gea E, Perrot JC, Lopez I. An unusual bilateral presentation of Frey’s Syndrome treated with botulinum toxin. Presentación infrecuente de síndrome de Frey bilateral, tratado con toxina botulínica. Rehabil (Madr) 2016; 50(2): 129–132.
  • Avellanet M, Sala-Blanch X, Rodrigo L, Gonzalez-Viejo MA. Permanent upper trunk plexopathy after interscalene brachial plexus block. J Clin Monit Comput 2016 Feb;30(1):51-4.
  • Gea E., Gil E., Pérez F. A., Pérez R. A., Roca A., Avellanet M. Health Sciences and Healthcare Research Group (HSHRG) of the University of Andorra. Medicamentos huérfanos: evolcuión e impacto. 20 Congreso Nacional Farmaceutico. Castellón. Comunicació Escrita.
  • Roca Montañana A., Gea Rodríguez E., Gil Máñez E.,Pérez Feliu A.,Pérez Ricart A. Seguridad en técnicas de administracion de medicamentos en pacientes con disfagia.  61. Congreso Nacional Sociedad Española Farmacia Hospitalaria.2016. Comunicació Escrita        
  • Perrot JC, Gabernet A. Disfagia a l’ HNSM. Hospital N Sra de Meritxell- Andorra : 2/6/2016. Sessió clínica.

2015: 

  • Tutte ML, Avellanet M, Valero O, Haro D, Torrero I. The association of WOMAC, HSS and isokinetic strength and fatigue of knee muscles in people with osteoarthritis following total knee replacement. Isokinetics and Exercise Science 2015;23:61–67.
  • MEDICAMENTS ORFES I MALALTIES RARES. PREVALENÇA A ANDORRA. PART I :  CARACTERISTIQUES ESPECIFIQUES. , De què parlem?. Gea E, Avellanet M. Comunicació Escrita. Butlletí UDA.
  • MEDICAMENTS ORFES I MALATIES RARES. PREVALENÇA A ANDORRA. PART II :  IMPACTE ECONOMIC. Gea E, Avellanet M. Comunicació Escrita. Butlletí UDA.
  • GRUP DE RECERCA EN SARCOPÈNIA, FRAGILITAT I DEPENDÈNCIA. Hospital de Mataró. Calendari de sessions 2015. Gea E, Avellanet M. Ponència sobre la Classificació internacional de funcionalitat (OMS). Comunicació oral.

2014:

  • Pharmacoepidemiology: ABORDAJE DE LA PATOLOGIA INFECCIOSA RESPIRATORIA EN URGENCIAS PEDIATRICAS HOSPITALARIAS. Gea E, Avellanet M, Estrada J, Medina M and Health Sciences and Healthcare Research Group (HSHRG) of the University of Andorra. 59 Congres de la Sociedad Española de Farmàcia Hospitalària. Comunicació Escrita.

2012: 

  • Pharmacoepidemiology: ORPHAN DRUGS AND RARE DISEASES IN ANDORRA. Gea E, Gil E, Barral N, Gonzalez V, Soler A, Avellanet M and Health Sciences and Healthcare Research Group (HSHRG) of the University of Andorra Pharmacy, Physical medicine and rehabilitation, Hospital Nostra Senyora de Meritxell, Escaldes, Andorra. European Symposium On Clinical Pharmacy. Comunicació Escrita.
  • Pharmacoepidemiology: MANAGEMENT OF URINARY TRACT INFECTION IN A PAEDIATRIC EMERGENCY DEPARTMENT. Gea E, Avellanet M, Estrada J, Medina M and Health Sciences and Healthcare Research Group (HSHRG) of the University of Andorra. European Symposium On Clinical Pharmacy. Comunicació Escrita.

2009: 

  • Pharmacoepidemiology: ANTIBIOTIC PRESCRIPCION IN A PAEDIATRIC EMERGENCY DEPARTMENT . Gea E, Avellanet M, Medina M, Santamaria V and Health Sciences and Healthcare Research Group (HSHRG) of the University of Andorra. European Symposium On Clinical Pharmacy. Comunicació Escrita.